Chronic Myeloid Leukemia
Not Applicable
- Conditions
- Health Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positive
- Registration Number
- CTRI/2021/08/035398
- Lead Sponsor
- DRREETIKA RAMANATHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Newly diagnosed cases of CML. 2.Follow up cases of CML
Exclusion Criteria
1.Patients who are unwilling to give written informed consent.
2.Patients lost to follow up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients will be categorized into various CML phases based on WHO criteria and stratified into risk Scores based on prognostic scoring system. <br/ ><br>Timepoint: 6 months
- Secondary Outcome Measures
Name Time Method Clinico-hematological response of follow up patients will be assessed. <br/ ><br>(for 3-6 months whenever possible). <br/ ><br>Timepoint: 3-6 months